Is META stock poisoned?

=== SUMMARY === - Post is a frustrated update from a META shareholder who has held a large position since November 2025 and is disappointed by the stock’s persistent declines despite strong earnings. - The author’s implicit thesis is that META has good fundamentals but remains “poisoned” by recurring headwinds: heavy capex, geopolitical fears, bond-market volatility, and lawsuits. - Quality assessment: This is emotional venting / retail speculation, not well-researched DD. It lacks valuation analysis, price targets, or a clear investment framework. === SENTIMENT === MIXED === TRADE IDEAS === META - WATCH | confidence: 0.50 | sentiment: -0.30 Speaker: u/GanacheCharming8737 Thesis: 1. THE FACT: The author holds a large META position that has underperformed since late 2025, even while the company posts strong earnings growth. 2. THE BRIDGE: The disconnect between earnings power and stock price creates a potential long-term opportunity, but only once the repeated negative catalysts stop weighing on sentiment. 3. THE VERDICT: This is not a clear buy or sell signal; the stock is worth watching for a stabilization point, especially around capex discipline and legal/macro headlines. 4. RISKS: Rising capex may structurally lower returns; Zuck’s supervoting control limits governance pushback; lawsuits and macro shocks can keep the stock range-bound. Timeframe: medium-term Key Points: - Author is long but frustrated, no exit plan - Strong earnings offset by heavy CAPEX concerns - Geopolitics, bonds, and lawsuits are overhangs - Comments are split: bearish on business model, bullish long-term - WATCH until key catalysts resolve === COMMENTS SUMMARY === Top commenters push back on the long thesis: one argues META ruined its asset-light business model by becoming a heavy capex company, while another notes the author has held for less than a year and is judging too short-term. A third comments that Zuck’s perpetual control justifies a structural discount, while another advises